Market Place
Sourcing Support
Vasomune: FDA Fast Track For Investigational Medicine AV-001
28 May 2024 //
BUSINESSWIRE
Vasomune Announces Poster Presentation at the ATS International Conference
06 May 2024 //
BUSINESSWIRE
ATS Selects Vasomune For AV-001 Respiratory Summit
15 Apr 2024 //
BUSINESSWIRE
Vasomune & AnGes Announce AV-001 Receives Positive Recommendation from the IDSMB
14 Nov 2023 //
BUSINESSWIRE
Vasomune, AnGes Enroll First Patient in Phase 2a Evaluating AV-001
18 Jan 2022 //
BUSINESSWIRE
Vasomune reports positive data from vascular normalisation therapy trial
26 Mar 2021 //
CLINICALTRIALSARENA
Vasomune Announces Preliminary Positive Ph1 Clinical Trial Results for Vascular
25 Mar 2021 //
BUSINESSWIRE
Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results
25 Mar 2021 //
BUSINESSWIRE
Vasomune Announces FDA Allowance of IND Application For AV-001
12 Nov 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.